Abstract title: A randomized comparison of continued zidovudine plus lamivudine BID (Combivir, CBV) versus switching to tenofovir DF plus emtricitabine (Truvada, TVD) each plus efavirenz (EFV) in stable HIV infected persons: results of a planned 24 week analysis
Author name: Graeme Moyle

Your full name:

Your e-mail:

Message: (max. 2000 characters)

 (please click only ONCE and wait, as it takes a few seconds)

Please note that your message might be read by IAS staff.